EMA Risk Management Virtual Information Day

Registered participants find access to the virtual conference in their DIA account. This virtual information day provides an update of ongoing Agency’s activities on medicines’ risk management.

Volver a Agenda

Log-in and Welcome Note by the Session Chairs

Session Chair(s)

Martin Huber, MPH, MPHARM

Pharmacovigilance Risk Assessment Committee (PRAC) Vice Chair

Federal Institute for Drugs and Medical Devices (BfArM), Germany

Maria Giovanna Satta

Scientific Officer in the Office of Therapies for Neurological and Psychiatric D

European Medicines Agency, Netherlands

¿Tiene una cuenta?